Having endured a rocky road over the past 12 months where their major project was rejected by the regulatory board three times, property developer Mustera Property Group (ASX: MPX) is finally set to get their Forbes project underway having received approval from the Joint Development Assessment Panel (JDAP). The $65m ‘Forbes Residences’ project located in
Read More
Australian fintech company Novatti Group (ASX: NOV) has reported a 67% rise in revenues from their payments processing business, a record for the company which has seen heightened activity amidst coronavirus lockdowns as businesses turn to digital payment solutions. For the quarter ending 31 March 2020, Novatti’s $1.72 million (unaudited) in payment processing revenue represented
Read More
Cannabinoid company Botanix Pharmaceuticals (ASX: BOT) has found its way into the fast lane towards FDA approval for their antimicrobial product BTX 1801, developed to prevent post-surgical infections, having secured Qualified Infectious Disease Product (QIPD) designation which will expedite their FDA review process. The designation of QIPD status for BTC 1801 is the first for
Read More
As the coronavirus pandemic continues to wreak havoc on the retail sector where, with populations in mass lockdown, COVID-19 has claimed another brand scalp with Radio Rentals to permanently close their 62 appliance stores. The news will be bitterly disappointing for people like Vic Vinegar who has been renting various radios to stay informed on
Read More
“Don’t fight the Fed” as you are being paid to take risks. Your investment thesis on asset classes at this present moment will be to follow the Fed (or central bank) dollar. Moral hazard is too costly it seems, and the latest unprecedented stimulus measures announced by the U.S. Fed in corporate credit markets highlights that the “whatever
Read More